MDXHEALTH (MDXH) Stock Analyst Earnings Estimates
NASDAQ:MDXH - Nasdaq - BE0974461940 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.24M 20.48% | 37.05M 66.59% | 70.193M 89.45% | 90.384M 28.76% | 108.38M 19.91% | 122.95M 13.44% | 145.7M 18.50% | |
| EBITDA YoY % growth | -23.8M -1.19% | -32.95M -38.45% | -20.468M 37.88% | -17.578M 14.12% | -475.83K 97.29% | 10.475M 2,301.42% | 31.038M 196.31% | |
| EBIT YoY % growth | -26.84M 0.04% | -37.86M -41.06% | -27.327M 27.82% | -24.695M 9.63% | -9.654M 60.91% | -71.91K 99.26% | 20.624M 28,780.29% | |
| Operating Margin | -120.68% | -102.19% | -38.93% | -27.32% | -8.91% | -0.06% | 14.16% | |
| EPS YoY % growth | N/A 40.69% | -0.82 64.36% | -1.59 -94.65% | -1.23 22.81% | -0.55 54.99% | -0.30 45.08% | 0.08 126.89% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 49.78% | -0.18 40.77% | -0.15 64.79% | -0.12 70.04% | -0.12 38.80% | -0.14 22.22% | -0.04 72.41% | -0.05 57.45% | -0.03 74.47% |
| Revenue Q2Q % growth | 23.827M 22.83% | 23.86M 20.30% | 27.216M 22.82% | 28.503M 22.24% | 28.242M 18.53% | 23.256M -2.53% | 30.498M 12.06% | 29.172M 2.35% | 30.396M 7.63% |
| EBITDA Q2Q % growth | -2.955M 26.27% | -1.742M 62.96% | -454.237K 95.60% | 639.203K 119.67% | 480.757K 116.27% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.104M 53.03% | -4.358M 34.00% | -2.56M 81.74% | -1.698M 67.61% | -1.749M 65.74% | -5.712M -31.06% | -918K 64.14% | -1.122M 33.91% | -102K 94.17% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.40 | -0.28 | -0.12 | -45.24% |
| Q2 2024 Q2Q % growth | -0.42 -40.00% | -0.27 | -0.15 | -55.38% |
| Q1 2024 Q2Q % growth | -0.31 38.00% | -0.31 | 0.00 | -1.31% |
| Q4 2023 Q2Q % growth | -0.39 64.55% | -0.11 | -0.28 | -247.59% |
| Q3 2023 Q2Q % growth | -0.40 2.06% | -0.20 | -0.20 | -104.25% |
| Q2 2023 Q2Q % growth | -0.30 | -0.22 | -0.08 | -34.92% |
| Q1 2023 Q2Q % growth | -0.50 -22.42% | -0.33 | -0.17 | -52.00% |
| Q4 2022 Q2Q % growth | -1.10 | -0.67 | -0.43 | -65.07% |
| Q3 2022 Q2Q % growth | -0.41 | -5.41 | 5.00 | 92.45% |
| Q2 2020 Q2Q % growth | -1.80 | -1.63 | -0.17 | -10.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 23.317M 20.50% | 21.91M | 1.407M | 6.42% |
| Q2 2024 Q2Q % growth | 22.159M 32.33% | 21.236M | 923K | 4.35% |
| Q1 2024 Q2Q % growth | 19.834M 34.93% | 18.574M | 1.26M | 6.78% |
| Q4 2023 Q2Q % growth | 19.398M -19.34% | 18.499M | 899K | 4.86% |
| Q3 2023 Q2Q % growth | 19.35M 73.48% | 18.354M | 996K | 5.43% |
| Q2 2023 Q2Q % growth | 16.745M 28.71% | 15.455M | 1.29M | 8.35% |
| Q1 2023 Q2Q % growth | 14.7M | 13.663M | 1.037M | 7.59% |
| Q4 2022 Q2Q % growth | 24.05M 108.95% | 12.58M | 11.47M | 91.18% |
| Q3 2022 Q2Q % growth | 11.154M | 9.761M | 1.393M | 14.27% |
| Q2 2022 Q2Q % growth | 13.01M 21.25% | % | ||
| Q4 2021 Q2Q % growth | 11.51M 34.15% | % | ||
| Q2 2021 Q2Q % growth | 10.73M 8.60% | % | ||
| Q4 2020 Q2Q % growth | 8.58M 842.86% | % | ||
| Q2 2020 Q2Q % growth | 9.88M -9.11% | 11.883M | -2.003M | -16.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0.55% | -0.7% |
| Revenue | 0% | 0% | 0% | 1.88% |